Zhenying Y. Zhang
Zhongshan Road 222
Dalian, China
Dalian, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial.
Journal: The British journal of dermatology
Published: May 21, 2026
A Clinically Accessible Nomogram for Identifying Likely Psoriatic Arthritis Among Patients with Psoriasis: A Multicenter Cross-Sectional Study.
Journal: Journal of clinical medicine
Published: May 07, 2026
Case Report: Successful treatment of dystrophic epidermolysis bullosa pruriginosa with upadacitinib in a patient with COL7A1, CARD14, and G6PD gene mutations.
Journal: Frontiers in medicine
Published: February 06, 2026
Telitacicept in combination with systemic steroid therapy in a patient with refractory pemphigus vulgaris and tuberculosis: a case report.
Journal: European journal of dermatology : EJD
Published: January 29, 2026
Case Report: Lupus miliaris disseminatus faciei successfully treated with thalidomide combined with photodynamic therapy: two cases and literature review.
Journal: Frontiers in immunology
Published: October 14, 2025
Clinical and histopathological correlates of elevated ligands of receptors for advanced glycation end products and type 2 cytokines in acquired reactive perforating collagenosis.
Journal: The British journal of dermatology
Published: August 31, 2025
The Psoriatic Disease Assessment Index (PSODAI) Score to Evaluate Systemic Involvement of Psoriasis.
The Psoriatic Disease Assessment Index (PSODAI) Score to Evaluate Systemic Involvement of Psoriasis.
Journal: Psoriasis (Auckland, N.Z.)
Published: June 21, 2025
Treatment of mesotherapy-induced skin fibro-proliferation with baricitinib.
Journal: European journal of dermatology : EJD
Published: May 26, 2025
Screening and transcriptomic analysis of anti-Sporothrix globosa targeting AbaA.
Journal: Frontiers in microbiology
Published: December 16, 2024
Efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled trial.
Journal: Chinese medical journal
Published: December 13, 2024
Annular pustular psoriasis: A heterogeneous subtype of generalized pustular psoriasis.
Journal: Chinese medical journal
Published: November 05, 2024
Last Updated: 09/26/2026